Authored By: Shrimayi Iyer
Nmims's Kirit. P. Mehta school of law, Mumbai
Case Title & Citation
Maria Sharapova v. International Tennis Federation (ITF)
CAS 2016/A/4643, Court of Arbitration for Sport (CAS), October 4, 2016 Background of the Case
In March 2016, Russian tennis star Maria Sharapova announced that she had tested positive for meldonium (also known as Mildronate) during the 2016 Australian Open. Meldonium had been added to the World Anti-Doping Agency (WADA) Prohibited List on January 1, 2016. Sharapova had been using the substance for medical reasons since 2006 and was unaware of its inclusion on the banned list. The International Tennis Federation (ITF) imposed a two-year suspension, which was later reduced to 15 months by the Court of Arbitration for Sport (CAS).
Facts of the Case
Substance Involved: Meldonium (Mildronate), a metabolic modulator used to treat heart conditions.
Date of Violation: January 26, 2016, following a doping control test at the Australian Open. * Sharapova’s Use: Prescribed by Dr. Anatoly Skalny in 2006 for medical reasons; continued use without awareness of its banned status.
Disclosure Issues: Failed to disclose meldonium use on doping control forms from 2014 to 2016.
Team’s Role: Manager Max Eisenbud was responsible for checking the WADA Prohibited List but did so inadequately.
Legal Issues
- Violation of Anti-Doping Rules: Whether Sharapova’s use of meldonium constituted a breach of the Tennis Anti-Doping Programme (TADP).
- Degree of Fault: Determining the extent of Sharapova’s fault in the violation.
- Appropriateness of Sanction: Whether the two-year suspension imposed by the ITF was proportionate.
Arguments
- Sharapova’s Defense:
- Unaware of meldonium’s inclusion on the banned list.
- Used the substance for medical purposes under a doctor’s supervision.
- No intention to enhance performance.
- Relied on her team’s responsibility to monitor the Prohibited List.
- ITF’s Arguments:
- Sharapova failed to ensure compliance with anti-doping rules.
- Negligence in disclosing meldonium use.
- Lack of transparency with her support team and medical advisors.
Court’s Analysis
The CAS panel acknowledged Sharapova’s lack of intent to violate anti-doping rules but emphasized her significant fault in failing to take necessary steps to ensure compliance. The tribunal found that Sharapova was the “sole author of her own misfortune,” highlighting her failure to disclose meldonium use and inadequate oversight of her team’s responsibilities. The CAS reduced the suspension to 15 months, considering the circumstances and Sharapova’s cooperation.
Decision
The Court of Arbitration for Sport reduced Maria Sharapova’s two-year suspension to 15 months, backdated to January 26, 2016. The CAS concluded that while Sharapova committed an anti-doping rule violation, her degree of fault was less than “significant,” warranting a reduced sanction.
Significance
The case underscores the importance of athletes’ responsibility to be aware of substances they consume and to ensure compliance with anti-doping regulations. It highlights the need for clear communication and diligence in monitoring changes to the Prohibited List. The reduced sanction reflects a nuanced approach to cases involving inadvertent violations, balancing accountability with fairness.
Conclusion
The Sharapova case serves as a critical example of the complexities in anti-doping jurisprudence, particularly concerning inadvertent violations. It emphasizes the dual responsibility of athletes to be informed about banned substances and to ensure their support teams are equally diligent. The CAS’s decision to reduce the suspension reflects a balanced approach, considering both the athlete’s intent and the need for adherence to anti-doping standards.
CITATION
- Decision in the Case of Maria Sharapova, Sports Integrity Initiative (2016).
- Maria Sharapova Wins CAS Appeal, Morgan Sports Law (2016).
- Treat for Tennis Fans – Sharapova Ban Reduced, Lex Counsel (2016).
- Tribunal Verdict Shatters Maria Sharapova’s Defence, The Irish Times (2016).
- Maria Sharapova Suspended for Two Years, CNN (2016).
